Literature DB >> 33202721

FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling.

Anastasia Knyazeva1, Aleksandr Khudiakov1, Raquel Vaz2, Aleksey Muravyev1, Ksenia Sukhareva1,3, Thomas Sejersen4, Anna Kostareva1,4.   

Abstract

Filamin C (FLNC), being one of the major actin-binding proteins, is involved in the maintenance of key muscle cell functions. Inherited skeletal muscle and cardiac disorders linked to genetic variants in FLNC have attracted attention because of their high clinical importance and possibility of genotype-phenotype correlations. To further expand on the role of FLNC in muscle cells, we focused on detailed alterations of muscle cell properties developed after the loss of FLNC. Using the CRISPR/Cas9 method we generated a C2C12 murine myoblast cell line with stably suppressed Flnc expression. FLNC-deficient myoblasts have a significantly higher proliferation rate combined with an impaired cell migration capacity. The suppression of Flnc expression leads to inability to complete myogenic differentiation, diminished expression of Myh1 and Myh4, alteration of transcriptional dynamics of myogenic factors, such as Mymk and Myog, and deregulation of Hippo signaling pathway. Specifically, we identified elevated basal levels of Hippo activity in myoblasts with loss of FLNC, and ineffective reduction of Hippo signaling activity during myogenic differentiation. The latter was restored by Flnc overexpression. In summary, we confirmed the role of FLNC in muscle cell proliferation, migration and differentiation, and demonstrated for the first time the direct link between Flnc expression and activity of TEAD-YAP\TAZ signaling. These findings support a role of FLNC in regulation of essential muscle processes relying on mechanical as well as signaling mechanisms.

Entities:  

Keywords:  FLNC; Hippo signaling; genome editing; myogenic differentiation

Mesh:

Substances:

Year:  2020        PMID: 33202721      PMCID: PMC7696573          DOI: 10.3390/genes11111343

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  36 in total

1.  De novo mutations in FLNC leading to early-onset restrictive cardiomyopathy and congenital myopathy.

Authors:  Artem Kiselev; Raquel Vaz; Anastasia Knyazeva; Aleksandr Khudiakov; Svetlana Tarnovskaya; Jiao Liu; Alexey Sergushichev; Sergey Kazakov; Dmitrij Frishman; Natalia Smolina; Tatiana Pervunina; John Jorholt; Gunnar Sjoberg; Tatiana Vershinina; Dmitriy Rudenko; Anders Arner; Thomas Sejersen; Anna Lindstrand; Anna Kostareva
Journal:  Hum Mutat       Date:  2018-06-17       Impact factor: 4.878

Review 2.  Gene regulatory networks and transcriptional mechanisms that control myogenesis.

Authors:  Margaret Buckingham; Peter W J Rigby
Journal:  Dev Cell       Date:  2014-02-10       Impact factor: 12.270

3.  RNA sequencing-based transcriptome profiling of cardiac tissue implicates novel putative disease mechanisms in FLNC-associated arrhythmogenic cardiomyopathy.

Authors:  Charlotte L Hall; Priyatansh Gurha; Maria Sabater-Molina; Angeliki Asimaki; Marta Futema; Ruth C Lovering; Mari Paz Suárez; Beatriz Aguilera; Pilar Molina; Esther Zorio; Cristian Coarfa; Matthew J Robertson; Sirisha M Cheedipudi; Keat-Eng Ng; Paul Delaney; Juan Pedro Hernández; Francisco Pastor; Juan R Gimeno; William J McKenna; Ali J Marian; Petros Syrris
Journal:  Int J Cardiol       Date:  2019-12-06       Impact factor: 4.164

4.  FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations.

Authors:  Flavie Ader; Pascal De Groote; Patricia Réant; Caroline Rooryck-Thambo; Delphine Dupin-Deguine; Caroline Rambaud; Diala Khraiche; Claire Perret; Jean François Pruny; Michèle Mathieu-Dramard; Marion Gérard; Yann Troadec; Laurent Gouya; Xavier Jeunemaitre; Lionel Van Maldergem; Albert Hagège; Eric Villard; Philippe Charron; Pascale Richard
Journal:  Clin Genet       Date:  2019-07-18       Impact factor: 4.438

5.  Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy.

Authors:  Nathan R Tucker; Micheal A McLellan; Dongjian Hu; Jiangchuan Ye; Victoria A Parsons; Robert W Mills; Sebastian Clauss; Elena Dolmatova; Marisa A Shea; David J Milan; Nandita S Scott; Mark Lindsay; Steven A Lubitz; Ibrahim J Domian; James R Stone; Honghuang Lin; Patrick T Ellinor
Journal:  Circ Cardiovasc Genet       Date:  2017-12

6.  Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C.

Authors:  Eyal Reinstein; Ana Gutierrez-Fernandez; Shay Tzur; Concetta Bormans; Shai Marcu; Einav Tayeb-Fligelman; Chana Vinkler; Annick Raas-Rothschild; Dana Irge; Meytal Landau; Mordechai Shohat; Xose S Puente; Doron M Behar; Carlos Lopez-Otın
Journal:  Eur J Hum Genet       Date:  2016-09-07       Impact factor: 4.246

7.  HSPB7 interacts with dimerized FLNC and its absence results in progressive myopathy in skeletal muscles.

Authors:  Liang-Yi Juo; Wern-Chir Liao; Yen-Ling Shih; Bih-Ying Yang; An-Bang Liu; Yu-Ting Yan
Journal:  J Cell Sci       Date:  2016-02-29       Impact factor: 5.285

8.  High filamin-C expression predicts enhanced invasiveness and poor outcome in glioblastoma multiforme.

Authors:  Muhammad Kamil; Yoshinari Shinsato; Nayuta Higa; Takuro Hirano; Masashi Idogawa; Tomoko Takajo; Kentaro Minami; Michiko Shimokawa; Masatatsu Yamamoto; Kohichi Kawahara; Hajime Yonezawa; Hirofumi Hirano; Tatsuhiko Furukawa; Koji Yoshimoto; Kazunori Arita
Journal:  Br J Cancer       Date:  2019-03-14       Impact factor: 7.640

9.  VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.

Authors:  Nicolas Figeac; Abdalla D Mohamed; Congshan Sun; Martin Schönfelder; David Matallanas; Amaya Garcia-Munoz; Edoardo Missiaglia; Elaina Collie-Duguid; Vanessa De Mello; Ajaybabu V Pobbati; Johanna Pruller; Oihane Jaka; Stephen D R Harridge; Wanjin Hong; Janet Shipley; Neil Vargesson; Peter S Zammit; Henning Wackerhage
Journal:  J Cell Sci       Date:  2019-07-05       Impact factor: 5.285

10.  Genetic Spectrum of Idiopathic Restrictive Cardiomyopathy Uncovered by Next-Generation Sequencing.

Authors:  Anna Kostareva; Artem Kiselev; Alexandra Gudkova; Goar Frishman; Andreas Ruepp; Dmitrij Frishman; Natalia Smolina; Svetlana Tarnovskaya; Daniel Nilsson; Anna Zlotina; Tatiana Khodyuchenko; Tatiana Vershinina; Tatiana Pervunina; Alexandra Klyushina; Andrey Kozlenok; Gunnar Sjoberg; Irina Golovljova; Thomas Sejersen; Eugeniy Shlyakhto
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

View more
  2 in total

1.  Comprehensive analysis of tumor microenvironment and identification of an immune signature to predict the prognosis and immunotherapeutic response in lung squamous cell carcinoma.

Authors:  Jinlong Wu; Chengfeng Xu; Xin Guan; Da Ni; Xuhui Yang; Zhiyin Yang; Mingsong Wang
Journal:  Ann Transl Med       Date:  2021-04

2.  Special Issue "Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy".

Authors:  Virginia Arechavala-Gomeza; Lidia Gonzalez-Quereda
Journal:  Genes (Basel)       Date:  2021-02-08       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.